Cargando…

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers

The presented cases describe the concurrent SARS-CoV-2 infection and inactivated SARS-CoV-2 vaccination among eight healthcare workers (HCWs). These cases highlighted the importance of broad hospital screening during the COVID-19 vaccination campaign. Further study regarding the durability of antibo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cucunawangsih, Cucunawangsih, Wijaya, Ratna Sari, Hardjo Lugito, Nata Pratama, Suriapranata, Ivet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566068/ https://www.ncbi.nlm.nih.gov/pubmed/34745670 http://dx.doi.org/10.1155/2021/3006251

Ejemplares similares

Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2021)

Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2022)

Recurrence of Asymptomatic COVID-19 after Recovery among Healthcare Workers
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2022)

Safety and Immunogenicity of a Single Dose of BNT162b2 COVID-19 mRNA Vaccine in a Warfarin-Treated Protein S Deficient Patient: A Case Report and Literature Review
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2022)

How Does Mucorales Benefit from the Dysregulated Iron Homeostasis During SARS-CoV-2 Infection?
por: Lugito, Nata Pratama Hardjo, et al.
Publicado: (2021)

Post-vaccination cases of COVID-19 among healthcare workers at Siloam Teaching Hospital, Indonesia
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2021)

REACTOGENICITY OF HETEROLOGOUS MRNA-BASED COVID-19 VACCINE BOOSTER IN YOUNG ADULTS IN INDONESIA- A SHORT COMMUNICATION.
por: Neneng, SURYADINATA, et al.
Publicado: (2023)

Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or “just” a marker of bacterial coinfection?
por: Lugito, Nata Pratama Hardjo
Publicado: (2021)

Trends of Dengue Disease Epidemiology
por: Cucunawangsih,, et al.
Publicado: (2017)

Antimicrobial Resistance of Salmonella enterica Serovars Typhi and Paratyphi Isolates from a General Hospital in Karawaci, Tangerang, Indonesia: A Five-Year Review
por: Hardjo Lugito, Nata Pratama, et al.
Publicado: (2017)

A Lethal Case of Sphingomonas paucimobilis Bacteremia in an Immunocompromised Patient
por: Hardjo Lugito, Nata Pratama, et al.
Publicado: (2016)

Immunoglobulin G (IgG) to IgM ratio in secondary adult dengue infection using samples from early days of symptoms onset
por: Cucunawangsih, et al.
Publicado: (2015)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Alopecia areata after SARS-CoV-2 vaccination
por: Scollan, Margaret E., et al.
Publicado: (2021)

Gross Hematuria following SARS-CoV-2 Vaccination
por: Sattari, Maryam, et al.
Publicado: (2023)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

Inactivation of SARS-CoV-2 by gamma irradiation
por: Jain, Rajlaxmi, et al.
Publicado: (2021)

Inactivating SARS-CoV-2 by electrochemical oxidation
por: Tu, Yunchuan, et al.
Publicado: (2021)

Assessment of inactivation procedures for SARS-CoV-2
por: Auerswald, Heidi, et al.
Publicado: (2021)

Inactivation of SARS-CoV-2 Laboratory Specimens
por: Haddock, Elaine, et al.
Publicado: (2021)

Inactivation of SARS-CoV-2 by Ozonated Glycerol
por: Takeda, Yohei, et al.
Publicado: (2021)

PMMA Microcapsules for the Inactivation of SARS-CoV-2
por: Sousa, Vânia I., et al.
Publicado: (2022)

SARS-CoV-2 in environmental perspective: Occurrence, persistence, surveillance, inactivation and challenges
por: Mohan, S. Venkata, et al.
Publicado: (2021)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

Occurrence of SARS-CoV-2 in the intraocular milieu
por: List, Wolfgang, et al.
Publicado: (2020)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
por: Zhou, Huan, et al.
Publicado: (2021)

Myofascial pain syndrome and SARS-CoV-2: a case series
por: Patel, Jaldhi, et al.
Publicado: (2021)

Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series
por: Messina, Emanuela, et al.
Publicado: (2021)

Small fiber neuropathy as a complication of SARS-CoV-2 vaccinations
por: Finsterer, Josef
Publicado: (2022)

SARS-CoV-2 Viral Sepsis with Meningoencephalitis
por: Dharsandiya, Mitkumar, et al.
Publicado: (2020)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
por: Abdelghany, T.M., et al.
Publicado: (2021)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals
por: Li, Meng, et al.
Publicado: (2023)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Petersen, Eskild, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gjuti48cg5b0qmno2bph03ti5f